Insulin and epidermal growth factor stimulate poly ADP-ribosylation.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D002478:Cells, Cultured; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005347:Fibroblasts / Q000187:drug effects / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology*; D007700:Kinetics; D051379:Mice; D008807:Mice, Inbred BALB C; D009243:NAD / Q000494:pharmacology; D009536:Niacinamide / Q000494:pharmacology; D009702:Nucleoside Diphosphate Sugars / Q000096:biosynthesis*; D010455:Peptides / Q000494:pharmacology*; D011064:Poly Adenosine Diphosphate Ribose / Q000096:biosynthesis*
D007328:Insulin; D009702:Nucleoside Diphosphate Sugars; D010455:Peptides; D009243:NAD; D009536:Niacinamide; D011064:Poly Adenosine Diphosphate Ribose; D004815:Epidermal Growth Factor; D015056:1-Methyl-3-isobutylxanthine